These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37965504)

  • 1. An extraordinary wave of SARS-CoV2, the youngest and the least serious.
    Justribó E; Falcon A; Ruiz-Vert MJ; Porque J; Gros S; Yuguero O
    Front Public Health; 2023; 11():1238045. PubMed ID: 37965504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main differences between the first and second waves of COVID-19 in Madrid, Spain.
    Soriano V; Ganado-Pinilla P; Sanchez-Santos M; Gómez-Gallego F; Barreiro P; de Mendoza C; Corral O
    Int J Infect Dis; 2021 Apr; 105():374-376. PubMed ID: 33684560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individuals With SARS-CoV-2 Infection During the First and Second Waves in Catalonia, Spain: Retrospective Observational Study Using Daily Updated Data.
    Alves-Cabratosa L; Comas-Cufí M; Blanch J; Martí-Lluch R; Ponjoan A; Castro-Guardiola A; Hurtado-Ganoza A; Pérez-Jaén A; Rexach-Fumaña M; Faixedas-Brunsoms D; Gispert-Ametller MA; Guell-Cargol A; Rodriguez-Batista M; Santaularia-Font F; Orriols R; Bonnin-Vilaplana M; Calderón López JC; Sabater-Talaverano G; Queralt Moles FX; Rodriguez-Requejo S; Avellana-Revuelta E; Balló E; Fages-Masmiquel E; Sirvent JM; Lorencio C; Morales-Pedrosa JM; Ortiz-Ballujera P; Ramos R
    JMIR Public Health Surveill; 2022 Jan; 8(1):e30006. PubMed ID: 34797774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain).
    Piron M; Jané M; Ciruela P; Basile L; Martínez A; Puig L; Bes M; Sauleda S
    Blood Transfus; 2022 Sep; 20(5):353-361. PubMed ID: 35175189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating epidemiological distribution (temporality and intensity) of respiratory pathogens following COVID-19 de-escalation process in Catalonia, September 2016-June 2021: Analysis of regional surveillance data.
    Guadalupe-Fernández V; Martínez-Solanas E; Sabrià-Sunyé A; Ferrer-Mikoly C; Martínez-Mateo A; Ciruela-Navas P; Mendioroz J; Basile L;
    PLoS One; 2024; 19(2):e0285892. PubMed ID: 38335176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain).
    Andrés C; Piñana M; Borràs-Bermejo B; González-Sánchez A; García-Cehic D; Esperalba J; Rando A; Zules-Oña RG; Campos C; Codina MG; Blanco-Grau A; Colomer-Castell S; Martín MC; Castillo C; García-Comuñas K; Vásquez-Mercado R; Martins-Martins R; Saubi N; Campins-Martí M; Pumarola T; Quer J; Antón A
    Emerg Microbes Infect; 2022 Dec; 11(1):172-181. PubMed ID: 34842496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.
    Berger JM; Gansterer M; Trutschnig W; Bathke AC; Strassl R; Lamm W; Raderer M; Preusser M; Berghoff AS
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):909-914. PubMed ID: 34410467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 Sentinel Schools Network of Catalonia (CSSNC) project: Associated factors to prevalence and incidence of SARS-CoV-2 infection in educational settings during the 2020-2021 academic year.
    Ganem F; Bordas A; Folch C; Alonso L; Montoro-Fernandez M; Colom-Cadena A; Mas A; Mendioroz J; Asso L; Anton A; Pumarola T; González MV; Blanco I; Soler-Palacín P; Soriano-Arandes A; Casabona J;
    PLoS One; 2022; 17(11):e0277764. PubMed ID: 36395191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
    Mondejar-Lopez P; Moreno-Galarraga L; de Manuel-Gomez C; Blitz-Castro E; Bravo-Lopez M; Gartner S; Perez-Ruiz E; Caro-Aguilera P; Sanz-Santiago V; Lopez-Neyra A; Luna-Paredes C; Garcia-Gonzalez M; Costa-Colomer J; Cols-Roig M; Delgado-Pecellin I; Castillo-Corullon S; Ruiz de Valbuena-Maiz M; Garcia-Marcos PW; Aguilar-Fernandez AJ; Martin-De Vicente C; Barajas-Sanchez MV; Mesa-Medina O; Bover-Bauza C; Figuerola-Mulet J; Garcia-Aviles B; Rodriguez-Saez MJ; Garcia-Magan C; Juarez-Marruecos P; Gutierrez-Martinez JR; Cortell-Aznar I; Gomez-Pastrana D; Velasco-Gonzalez MV; Barrio MI; Sanchez-Solis M; Asensio de la Cruz O; Pastor-Vivero MD
    Pediatr Pulmonol; 2023 Nov; 58(11):3195-3205. PubMed ID: 37589420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
    Marks M; Millat-Martinez P; Ouchi D; Roberts CH; Alemany A; Corbacho-Monné M; Ubals M; Tobias A; Tebé C; Ballana E; Bassat Q; Baro B; Vall-Mayans M; G-Beiras C; Prat N; Ara J; Clotet B; Mitjà O
    Lancet Infect Dis; 2021 May; 21(5):629-636. PubMed ID: 33545090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First wave of the COVID-19 pandemic in Navarre, Spain, February-June 2020].
    Castilla J; Moreno-Iribas C; Ibero Esparza C; Martínez-Baz I; Trobajo-Sanmartín C; Ezpeleta C; Guevara M; En Navarra GPEEC
    An Sist Sanit Navar; 2022 Mar; 45(1):. PubMed ID: 34142991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.
    Robert T; Lano G; Resseguier N; Bobot M; Bouchouareb D; Burtey S; de Lamballerie X; Dhorne J; Dussol B; Duval A; Faraut J; Fourié T; Giaime P; Hallah M; Jaubert D; Jéhel O; Legris T; Liotatis S; Moal V; Ninove L; Pedinielli N; Pelletier M; Romeu-Giannoli M; Saba M; Sallée M; Samson L; Saveanu A; Scarfoglière V; Sebahoun P; Vial R; Von Kotze C; Brunet P; Lebrun G; Bataille S; Jourde-Chiche N
    Sci Rep; 2022 Jul; 12(1):11972. PubMed ID: 35831388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of environmental SARS-CoV-2 RNA in a high prevalence setting in Spain.
    Fernández-de-Mera IG; Rodríguez Del-Río FJ; de la Fuente J; Pérez-Sancho M; Hervás D; Moreno I; Domínguez M; Domínguez L; Gortázar C
    Transbound Emerg Dis; 2021 May; 68(3):1487-1492. PubMed ID: 32894654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic consumption before and during COVID-19 in Asturias, Spain.
    García MLN; Martínez PF; Bretón EF; Martínez Alfonso MM; Gil PS
    BMC Public Health; 2023 Mar; 23(1):494. PubMed ID: 36918825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil.
    Soares GDS; Morais LV; Silva KCN; Ferreira EM; Shio MT; Romano CM; Conde CR; Sabino EC; França CN; Nali LH
    Rev Inst Med Trop Sao Paulo; 2022; 64():e46. PubMed ID: 35749418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.
    Crespo J; Lazarus JV; Iruzubieta P; García F; García-Samaniego J;
    J Hepatol; 2021 Jul; 75(1):224-226. PubMed ID: 33757805
    [No Abstract]   [Full Text] [Related]  

  • 20. A Review of Brooke Army Medical Center Chaplaincy Service During the SARS-COV2 Pandemic: Implications for Service Structure and Patient Needs.
    Bauer Z; Sherwin J; Smith S; Radowsky J
    Mil Med; 2023 Mar; 188(3-4):e824-e828. PubMed ID: 34453171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.